MicroPort NeuroTech Ltd
HKEX:2172
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its 3-Year Average (22.5), the stock would be worth HK$8.12 (22% downside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 28.9 | HK$10.4 |
0%
|
| 3-Year Average | 22.5 | HK$8.12 |
-22%
|
| 5-Year Average | 22.5 | HK$8.12 |
-22%
|
| Industry Average | 19.5 | HK$7.03 |
-32%
|
| Country Average | 18.3 | HK$6.58 |
-37%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
M
|
MicroPort NeuroTech Ltd
HKEX:2172
|
6B HKD | 28.9 | 28.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
165.7B USD | 54.7 | 58 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
163B USD | 17 | 26 | |
| US |
|
Stryker Corp
NYSE:SYK
|
122.9B USD | 24.4 | 37.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
105.1B USD | 14.4 | 22.8 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
86.7B USD | 19.1 | 24.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.8B USD | 30 | 43.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
39.8B EUR | 13.1 | 18.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.3B USD | 38.3 | 42.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
42.6B USD | 12.5 | 24.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
31.6B USD | 16.5 | 21.3 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 9.8 |
| Median | 18.3 |
| 70th Percentile | 36.5 |
| Max | 266 666.7 |
Other Multiples
MicroPort NeuroTech Ltd
Glance View
MicroPort NeuroTech Ltd is a CN-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2022-07-15. MicroPort NeuroTech Ltd is a China-based investment holding company. The firm is principally engaged in the research and development, manufacturing and sales of neuro-interventional medical devices. The firm's main products include embolization coils, flow-diverting stents and stent grafts. The firm's products mainly cover three major areas of neurovascular diseases, namely hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke. The firm mainly operates its businesses in the domestic and overseas markets.
